176 related articles for article (PubMed ID: 10471519)
1. Molecular effects of paclitaxel: myths and reality (a critical review).
Blagosklonny MV; Fojo T
Int J Cancer; 1999 Oct; 83(2):151-6. PubMed ID: 10471519
[TBL] [Abstract][Full Text] [Related]
2. Low concentrations of paclitaxel induce cell type-dependent p53, p21 and G1/G2 arrest instead of mitotic arrest: molecular determinants of paclitaxel-induced cytotoxicity.
Giannakakou P; Robey R; Fojo T; Blagosklonny MV
Oncogene; 2001 Jun; 20(29):3806-13. PubMed ID: 11439344
[TBL] [Abstract][Full Text] [Related]
3. Taxol-mediated augmentation of CD95 ligand-induced apoptosis of human malignant glioma cells: association with bcl-2 phosphorylation but neither activation of p53 nor G2/M cell cycle arrest.
Roth W; Wagenknecht B; Grimmel C; Dichgans J; Weller M
Br J Cancer; 1998; 77(3):404-11. PubMed ID: 9472635
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of Taxol-induced cell death are concentration dependent.
Torres K; Horwitz SB
Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
[TBL] [Abstract][Full Text] [Related]
5. Taxol-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway.
Woods CM; Zhu J; McQueney PA; Bollag D; Lazarides E
Mol Med; 1995 Jul; 1(5):506-26. PubMed ID: 8529117
[TBL] [Abstract][Full Text] [Related]
6. Taxol-induced apoptosis depends on MAP kinase pathways (ERK and p38) and is independent of p53.
Bacus SS; Gudkov AV; Lowe M; Lyass L; Yung Y; Komarov AP; Keyomarsi K; Yarden Y; Seger R
Oncogene; 2001 Jan; 20(2):147-55. PubMed ID: 11313944
[TBL] [Abstract][Full Text] [Related]
7. Paclitaxel sensitivity correlates with p53 status and DNA fragmentation, but not G2/M accumulation.
Rakovitch E; Mellado W; Hall EJ; Pandita TK; Sawant S; Geard CR
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1119-24. PubMed ID: 10421546
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity.
Menendez JA; Vellon L; Colomer R; Lupu R
Int J Cancer; 2005 May; 115(1):19-35. PubMed ID: 15657900
[TBL] [Abstract][Full Text] [Related]
9. Arsenic trioxide produces polymerization of microtubules and mitotic arrest before apoptosis in human tumor cell lines.
Ling YH; Jiang JD; Holland JF; Perez-Soler R
Mol Pharmacol; 2002 Sep; 62(3):529-38. PubMed ID: 12181429
[TBL] [Abstract][Full Text] [Related]
10. Raf-1/bcl-2 phosphorylation: a step from microtubule damage to cell death.
Blagosklonny MV; Giannakakou P; el-Deiry WS; Kingston DG; Higgs PI; Neckers L; Fojo T
Cancer Res; 1997 Jan; 57(1):130-5. PubMed ID: 8988053
[TBL] [Abstract][Full Text] [Related]
11. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel.
Milross CG; Mason KA; Hunter NR; Chung WK; Peters LJ; Milas L
J Natl Cancer Inst; 1996 Sep; 88(18):1308-14. PubMed ID: 8797771
[TBL] [Abstract][Full Text] [Related]
12. Silencing of the novel p53 target gene Snk/Plk2 leads to mitotic catastrophe in paclitaxel (taxol)-exposed cells.
Burns TF; Fei P; Scata KA; Dicker DT; El-Deiry WS
Mol Cell Biol; 2003 Aug; 23(16):5556-71. PubMed ID: 12897130
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of paclitaxel-induced microtubule stabilization, mitotic arrest, and apoptosis by the microtubule-targeting agent EM012.
Zhou J; Liu M; Aneja R; Chandra R; Joshi HC
Biochem Pharmacol; 2004 Dec; 68(12):2435-41. PubMed ID: 15548390
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel-induced cell death: where the cell cycle and apoptosis come together.
Wang TH; Wang HS; Soong YK
Cancer; 2000 Jun; 88(11):2619-28. PubMed ID: 10861441
[TBL] [Abstract][Full Text] [Related]
15. p53-independent apoptosis induced by paclitaxel through an indirect mechanism.
Lanni JS; Lowe SW; Licitra EJ; Liu JO; Jacks T
Proc Natl Acad Sci U S A; 1997 Sep; 94(18):9679-83. PubMed ID: 9275183
[TBL] [Abstract][Full Text] [Related]
16. Exposure to low intensity ultrasound removes paclitaxel cytotoxicity in breast and ovarian cancer cells.
Amaya C; Luo S; Baigorri J; Baucells R; Smith ER; Xu XX
BMC Cancer; 2021 Sep; 21(1):981. PubMed ID: 34470602
[TBL] [Abstract][Full Text] [Related]
17. Sequential activation and inactivation of G2 checkpoints for selective killing of p53-deficient cells by microtubule-active drugs.
Blagosklonny MV
Oncogene; 2002 Sep; 21(41):6249-54. PubMed ID: 12214265
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis induced by low-dose paclitaxel is associated with p53 upregulation in nasopharyngeal carcinoma cells.
Tan G; Heqing L; Jiangbo C; Ming J; Yanhong M; Xianghe L; Hong S; Li G
Int J Cancer; 2002 Jan; 97(2):168-72. PubMed ID: 11774260
[TBL] [Abstract][Full Text] [Related]
19. Cyclin-dependent kinase 1-mediated phosphorylation of YES links mitotic arrest and apoptosis during antitubulin chemotherapy.
Wang Z; Chen X; Zhong MZ; Yang S; Zhou J; Klinkebiel DL; Karpf AR; Chen Y; Dong J
Cell Signal; 2018 Dec; 52():137-146. PubMed ID: 30223016
[TBL] [Abstract][Full Text] [Related]
20. Oxaliplatin, a potent inhibitor of survivin, enhances paclitaxel-induced apoptosis and mitotic catastrophe in colon cancer cells.
Fujie Y; Yamamoto H; Ngan CY; Takagi A; Hayashi T; Suzuki R; Ezumi K; Takemasa I; Ikeda M; Sekimoto M; Matsuura N; Monden M
Jpn J Clin Oncol; 2005 Aug; 35(8):453-63. PubMed ID: 16024531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
